Adaptive Biotechnologies Corp

SEC 4 · Filed

0001780649-26-000003Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 3, 2026

Sale by ROBINS CHAD M

Security
Common Stock
Code
S
Shares
2,380
Price per share
16.15
Structured facts
{
  "code": "S",
  "date": "2026-03-03",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025.",
    "F5": "The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.23, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."
  },
  "owners": [
    {
      "cik": "0001780649",
      "name": "ROBINS CHAD M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO and Chairman"
    }
  ],
  "ownership": "D",
  "post_shares": "1934247",
  "price": "16.15",
  "row": 4,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "2380",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 3, 2026

Sale by ROBINS CHAD M

Security
Common Stock
Code
S
Shares
50,703
Price per share
15.49
Structured facts
{
  "code": "S",
  "date": "2026-03-03",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025.",
    "F4": "The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.11 to $16.10, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."
  },
  "owners": [
    {
      "cik": "0001780649",
      "name": "ROBINS CHAD M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO and Chairman"
    }
  ],
  "ownership": "D",
  "post_shares": "1936627",
  "price": "15.49",
  "row": 3,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "50703",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 2, 2026

Sale by ROBINS CHAD M

Security
Common Stock
Code
S
Shares
289,024
Price per share
15.82
Structured facts
{
  "code": "S",
  "date": "2026-03-02",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025.",
    "F3": "The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.51 to $16.18, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."
  },
  "owners": [
    {
      "cik": "0001780649",
      "name": "ROBINS CHAD M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO and Chairman"
    }
  ],
  "ownership": "D",
  "post_shares": "1987330",
  "price": "15.82",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "289024",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by ROBINS CHAD M

Security
Common Stock
Code
S
Shares
182,891
Price per share
15.99
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025.",
    "F2": "The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.20, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."
  },
  "owners": [
    {
      "cik": "0001780649",
      "name": "ROBINS CHAD M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO and Chairman"
    }
  ],
  "ownership": "D",
  "post_shares": "2276354",
  "price": "15.99",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "182891",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}